JensonR+ (Ireland) Ltd (a subsidiary company of JensonR+ Ltd) was formed in January 2018 and is based in the Republic of Ireland.
The formation of this JensonR+ (Ireland) Ltd was part of the continued growth of the business, but by centring growth in Ireland we have been able to focus our preparations ahead of the changes that occurred when the United Kingdom exited the European Union. Our first Irish employees joined the company in January 2019. Due to the expected demands of Brexit, priority was given to establishing both quality systems (including an Irish resident Qualified Person) and a pharmacovigilance system (including an Irish resident Qualified Person for Pharmacovigilance).
At the beginning of Quarter 2 2019, JensonR+ (Ireland) Ltd was granted a Manufacturing Importation Authorisation by the Healthcare Products Regulatory Agency in Ireland.
JensonR+ (Ireland) Ltd currently offers a service holding Marketing Authorisations on behalf of clients, quality services (including batch release / certification for the European Union) and pharmacovigilance services. Wider support for regulatory, medical device and market access services is completed in conjunction with resources available in JensonR+ Ltd in the UK.
Since its formation, JensonR+ (Ireland) Ltd has also formed close alliances with independent quality control laboratories in Ireland for the completion of European Union based testing of medicinal products, and warehouse / distribution facilities in Ireland.